Transcription of 歐盟EMA於2012年7月提出「A型血友病患者產生抑 …
{{id}} {{{paragraph}}}
RegMed 2013 Vol. 31 1 1 2 (biological products) DNA (recombinant DNA technology) (cell line) 1921 DNA DNA 1973 Herbert Boyer Stanley Cohen (scalable) (venture capitalist) Robert Swanson Boyer Genentech ( Genentech )
RegMed 2013 Vol. 31 3 位進行反應,進而達到生理上和藥理上的作用。除此之外,蛋白質上常常有一些轉譯後 修飾 (post-translational modifications),例如glycoproteins,對生物製劑的療效有很大的
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}